Girihlet provides an immune map database. Its platform aims to accelerate immune diseases discovery, monitoring and therapeutic approaches.

All edits by  Meredith Hanel 

Edits on 31 Jan, 2021
Meredith Hanel
Meredith Hanel edited on 31 Jan, 2021
Edits made to:
Article (+253 characters)

Girihlet’s T and B cell sequencing assays and immune map database allow predictions and measurements on a person’s health status and provide an un understanding of the immune system in order to treat cancer, allergies, infections and autoimmune disease.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.